Correlation Between Zedge and Spyre Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Zedge and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zedge and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zedge Inc and Spyre Therapeutics, you can compare the effects of market volatilities on Zedge and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zedge with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zedge and Spyre Therapeutics.

Diversification Opportunities for Zedge and Spyre Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Zedge and Spyre is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Zedge Inc and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Zedge is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zedge Inc are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Zedge i.e., Zedge and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Zedge and Spyre Therapeutics

Given the investment horizon of 90 days Zedge is expected to generate 1.12 times less return on investment than Spyre Therapeutics. In addition to that, Zedge is 1.2 times more volatile than Spyre Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.05 per unit of volatility. If you would invest  1,640  in Spyre Therapeutics on September 14, 2024 and sell it today you would earn a total of  721.00  from holding Spyre Therapeutics or generate 43.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Zedge Inc  vs.  Spyre Therapeutics

 Performance 
       Timeline  
Zedge Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Zedge Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.
Spyre Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Zedge and Spyre Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Zedge and Spyre Therapeutics

The main advantage of trading using opposite Zedge and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zedge position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.
The idea behind Zedge Inc and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes